About: http://data.cimple.eu/news-article/745b4d6a4ca7a0667e92b083d47a199c09b2fbc75e3364b69189f300     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • A volunteer participating in clinical trials of the Covid-19 vaccine developed by Oxford University has died in Brazil, officials said Wednesday, though it was unclear whether he received the vaccine or a placebo. It is the first death reported in the various coronavirus vaccine trials taking place worldwide. However, organizers of the study said an independent review had concluded there were no safety concerns and that testing of the vaccine, developed with pharmaceutical firm AstraZeneca, would continue. Media reports said the volunteer was a 28-year-old doctor working on the front lines of the pandemic who died of complications from Covid-19. "All significant medical incidents, whether participants are in the control group or the Covid-19 vaccine group, are independently reviewed," Oxford said in a statement. "Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial, and the independent review in addition to the Brazilian regulator have recommended that the trial should continue." National health regulator Anvisa confirmed it had been "formally notified of the case on October 19" and had received a report on the independent review from the security and evaluation committee overseeing the study. The D'Or Teaching and Research Institute (IDOR), which is helping organize the tests in Brazil, said the independent review process had "raised no doubts about the safety of the study, and recommended it continue." Oxford and AstraZeneca previously had to suspend testing of the vaccine in September when a volunteer in Britain developed an unexplained illness. Trials resumed after British regulators and an independent review concluded the illness was not a side effect of the vaccine. Half the volunteers in the final-stage clinical trial -- a double-blind, randomized, controlled study -- receive a placebo, IDOR said. Around 8,000 volunteers have been vaccinated so far in Brazil, and more than 20,000 worldwide, it said. Study participants must be doctors, nurses or other health sector workers who come into regular contact with the virus. Brazilian newspaper Globo said the deceased volunteer was a young doctor who had been treating Covid-19 patients since March in the emergency rooms and intensive care units at two hospitals in Rio de Janeiro. He graduated from medical school last year, and was in good health prior to contracting the disease, family and friends told the newspaper. jhb/sst
schema:headline
  • Volunteer in Oxford Covid vaccine test dies in Brazil: officials
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software